Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01979133 · ClinicalTrials.gov registry record · Phase 3
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
A Phase 3 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01979133: Completed Phase 3 study, sponsored by University of Texas Southwestern Medical Center.
NCT01979133 is a Phase 3 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01979133, a Phase 3 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is being done to see if icariin will help with depression in patients with bipolar disorder and alcohol or cocaine use disorders. The pills used in this study contain 20% icariin.
Primary Outcome
HAMD is an observer-rated measure of depressive symptomatology: 1. 17 questions (answers for individual questions range between 0-3 and 0-4). Total score range: 0-52. No subscales for this measure. 2. 0 - no depression; 52 - very severe depression (lower score corresponds to a better outcome). 3. Total score is obtained by summing questions 1-17.
Interventions
- DRUG Icariin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
What the finished NCT01979133 record still lists
NCT01979133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Icariin is the first listed.
NCT01979133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01979133 about?
NCT01979133 is a clinical study titled "Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders". This study is being done to see if icariin will help with depression in patients with bipolar disorder and alcohol or cocaine use disorders. The pills used in this study contain 20% icariin.
What is the current status of trial NCT01979133?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2013-10. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01979133?
The interventions under investigation include: Icariin (DRUG).
Who is sponsoring clinical trial NCT01979133?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01979133's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia